Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO)
| Market Cap | n/a+95.2% |
| Revenue (ttm) | n/a+986.1% |
| Net Income | n/a+15.3% |
| EPS | n/a+45.6% |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 241,215 |
| Open | n/a |
| Previous Close | 5.84 |
| Day's Range | 5.64 - 5.86 |
| 52-Week Range | 2.78 - 6.50 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
Orchestra BioMed Holdings, Inc. has a live Insider Score.
Scored on 2 qualifying trades from 2 insiders in the last 90 days.
About OBIO
Orchestra BioMed Holdings, Inc. operates as an innovative company in the biomedical sector. Its leading product candidates are BackBeat Cardiac Neuromodulation Therapy (CNT), designed to manage hypertension, and the Virtue Sirolimus AngioInfusion Balloon (SAB), aimed at treating atherosclerotic artery disease. The company's offerings also encompass FreeHold retractors, which are solutions for minimally invasive surgical procedures. Orchestra BioMed has formed key alliances to advance its products: a strategic collaboration with Medtronic focuses on developing and commercializing BackBeat CNT for pacemaker-indicated patients suffering from hypertension. Additionally, a partnership with Terumo Corporation is dedicated to the development and market introduction of Virtue SAB for artery disease. The company's headquarters are located in New Hope, Pennsylvania.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$OBIO stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in OBIO holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by OBIO's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
OBIO Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New OBIO patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to OBIO from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in OBIO
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $7.41M |
| IWMiShares Russell 2000 ETF | $5.81M |
| VXFVanguard Extended Market ETF | $2.51M |
| IWOiShares Russell 2000 Growth ETF | $2.21M |
| SCHASchwab U.S. Small-Cap ETF | $1.33M |
| SURISimplify Propel Opportunities ETF | $1.24M |
Estimated from each fund’s disclosed top holdings × AUM
OBIO Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from OBIO’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score